Phare Bio
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.pharebio.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Phare Bio
Phare Bio is a social venture focused on utilizing generative AI and deep learning to discover new classes of antibiotics in response to the global antimicrobial resistance crisis. The company collaborates with the Collins Lab at MIT to develop AIBiotics, the world's first generative AI antibiotics discovery engine, aimed at addressing urgent threats posed by antibiotic-resistant bacteria. Phare Bio's unique business model combines donor funding for preclinical development with strategic partnerships for clinical trials, ensuring that novel antibiotic therapies reach those in greatest need. Backed by significant grants from organizations like TED's Audacious Project and Google.org, Phare Bio is committed to unlocking social impact through innovative healthcare solutions.Explore more
Phare Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phare Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Phare Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Phare Bio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Phare Bio had a recent Job posting/layoffs
Earning: See what the market has to say on Phare Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Phare Bio
Phare Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Phare Bio has new funding data
Product Launch: Get notified when Phare Bio launches new products
Recommended Actions
Reach out to Masked Content who joined Phare Bio as Masked Content
Find 2 more new buyers
Compare Similar Companies to Phare Bio
Compare insights from companies similar to Phare Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phare Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Phare Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Phare Bio.
Phare Bio Tech Stack
A closer look at the technologies used by Phare Bio
Phare Bio News & Media
Phare Bio Selected to Participate in the Google.org Accelerator: Generative AI to Advance Open-Access Antibiotic Discovery Platform
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Phare Bio, a biotech social venture using AI to combat the global antibiotic resistance crisis, has been selected to participate in the Google.org Accelerator: Generative AI – to advance its groundbreaking work in antibiotic research and development. Along with a share of $30 million in funding, Phare Bio will receive 6 months of pro bono technical expertise to support the continued buildout of Phare Bio’s AI-powered, open-access drug discovery platform – a rePhare Bio Awarded Up To $27 Million from ARPA-H to Accelerate AI-Powered Drug Discovery and Develop Critically Needed New Classes of Antibiotics
BOSTON--(BUSINESS WIRE)--Phare Bio, along with the Collins Lab at the Massachusetts Institute of Technology (MIT) and Harvard's Wyss Institute, today announced that they have been awarded up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), part of the U.S. Department of Health and Human Services, to enhance their generative artificial intelligence (AI) discovery platform and produce novel classes of antibiotics. With mounting concern around the AMR crisi
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Phare Bio
Sign Up For FreeTo access detailed company insights
Phare Bio is a social venture focused on utilizing generative AI and deep learning to discover new classes of antibiotics in response to the global antimicrobial resistance crisis. The company collaborates with the Collins Lab at MIT to develop AIBiotics, the world's first generative AI antibiotics discovery engine, aimed at addressing urgent threa... Read More
